Gonadotropin Releasing Hormone (GnRH) Agonists

Gonadotropin-releasing hormone agonists are synthetic decapeptide analogues of native GnRH that initially stimulate and then suppress gonadotropin secretion from the pituitary gland. Following initial receptor activation, continuous GnRH agonist exposure leads to receptor downregulation and reversible suppression of the hypothalamic-pituitary-gonadal axis, reducing sex steroid production.

Approved formulations include leuprolide, goserelin, and triptorelin, used primarily in hormone-sensitive cancers and reproductive medicine. The longevity rationale derives from theoretical models linking reduced reproductive signaling to extended lifespan observed in model organisms, though this remains speculative in humans..

Gonadotropin Releasing Hormone (GnRH) Agonists has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.